SF6 plasma etching of silicon nanocrystals.

PubWeight™: 0.92‹?›

🔗 View Article (PMID 19417298)

Published in Nanotechnology on December 17, 2008

Authors

R W Liptak1, B Devetter, J H Thomas, U Kortshagen, S A Campbell

Author Affiliations

1: Department of Electrical and Computer Engineering, University of Minnesota, Minneapolis, MN 55455, USA.

Articles by these authors

A Saccharomyces cerevisiae genomic plasmid bank based on a centromere-containing shuttle vector. Gene (1987) 19.68

Diverse effects of beta-tubulin mutations on microtubule formation and function. J Cell Biol (1988) 6.88

Isolation of the beta-tubulin gene from yeast and demonstration of its essential function in vivo. Cell (1983) 6.22

Genetic analysis of chemosensory control of dauer formation in Caenorhabditis elegans. Genetics (1992) 4.04

Isolation and characterization of mutations in the beta-tubulin gene of Saccharomyces cerevisiae. Genetics (1985) 3.77

A gene required for the separation of chromosomes on the spindle apparatus in yeast. Cell (1986) 3.32

A PDK1 homolog is necessary and sufficient to transduce AGE-1 PI3 kinase signals that regulate diapause in Caenorhabditis elegans. Genes Dev (1999) 3.21

Chemosensory neurons function in parallel to mediate a pheromone response in C. elegans. Neuron (1996) 3.19

Lethal paralysis of Caenorhabditis elegans by Pseudomonas aeruginosa. Proc Natl Acad Sci U S A (1999) 3.19

A transmembrane guanylyl cyclase (DAF-11) and Hsp90 (DAF-21) regulate a common set of chemosensory behaviors in caenorhabditis elegans. Genetics (2000) 2.90

The RFX-type transcription factor DAF-19 regulates sensory neuron cilium formation in C. elegans. Mol Cell (2000) 2.58

Mutations affecting the chemosensory neurons of Caenorhabditis elegans. Genetics (1995) 2.54

Chemosensory cell function in the behavior and development of Caenorhabditis elegans. Cold Spring Harb Symp Quant Biol (1990) 2.28

Studies on the enzymic degradation of L-serine O-sulphate by a rat liver preparation. Biochem J (1967) 2.17

Streptococcal infection in young pigs. II. Epidemiology and experimental production of the disease. J Hyg (Lond) (1966) 2.12

High-yield plasma synthesis of luminescent silicon nanocrystals. Nano Lett (2005) 2.11

Genetic analysis of the roles of daf-28 and age-1 in regulating Caenorhabditis elegans dauer formation. Genetics (1996) 2.01

The C. elegans homolog of the murine cystic kidney disease gene Tg737 functions in a ciliogenic pathway and is disrupted in osm-5 mutant worms. Development (2001) 2.01

Sequence of C. elegans lag-2 reveals a cell-signalling domain shared with Delta and Serrate of Drosophila. Nature (1994) 1.90

aex-3 encodes a novel regulator of presynaptic activity in C. elegans. Neuron (1997) 1.86

Genetic and pharmacological analysis of neurotransmitters controlling egg laying in C. elegans. J Neurosci (1995) 1.85

A screen for nonconditional dauer-constitutive mutations in Caenorhabditis elegans. Genetics (1994) 1.76

Regulation of a periodic motor program in C. elegans. J Neurosci (1994) 1.74

Dauer formation induced by high temperatures in Caenorhabditis elegans. Genetics (2000) 1.73

egl-4 acts through a transforming growth factor-beta/SMAD pathway in Caenorhabditis elegans to regulate multiple neuronal circuits in response to sensory cues. Genetics (2000) 1.71

Epiploic appendagitis. Surg Gynecol Obstet (1974) 1.64

eat-11 encodes GPB-2, a Gbeta(5) ortholog that interacts with G(o)alpha and G(q)alpha to regulate C. elegans behavior. Curr Biol (2001) 1.62

Dynamos in asymptotic-giant-branch stars as the origin of magnetic fields shaping planetary nebulae. Nature (2001) 1.51

Diverse behavioural defects caused by mutations in Caenorhabditis elegans unc-43 CaM kinase II. Nature (1999) 1.50

Multiple chemosensory defects in daf-11 and daf-21 mutants of Caenorhabditis elegans. Genetics (1994) 1.43

Post-thyroidectomy hypocalcemia. Incidence and risk factors. Am J Surg (1986) 1.41

Observation of an antimatter hypernucleus. Science (2010) 1.38

Neurosecretory control of aging in Caenorhabditis elegans. Proc Natl Acad Sci U S A (1999) 1.37

Calcium/calmodulin-dependent protein kinase II regulates Caenorhabditis elegans locomotion in concert with a G(o)/G(q) signaling network. Genetics (2000) 1.36

Influence of preformed antibody on experimental Streptococcus sanguis endocarditis. Infect Immun (1979) 1.36

Significance of lymph node metastases in patients with pancreatic cancer undergoing curative resection. Am J Surg (1996) 1.32

Genes that control a temperature-compensated ultradian clock in Caenorhabditis elegans. Proc Natl Acad Sci U S A (1995) 1.30

Targets of TGF-beta signaling in Caenorhabditis elegans dauer formation. Dev Biol (2000) 1.30

Improving resectability and survival in patients with primary duodenal carcinoma. Am J Surg (1993) 1.26

Fluoxetine-resistant mutants in C. elegans define a novel family of transmembrane proteins. Mol Cell (1999) 1.25

Characteristics of cystic neoplasms of the pancreas and results of aggressive surgical treatment. Am J Surg (1992) 1.21

Pancreaticoduodenectomy for malignant pancreatic and periampullary neoplasms in elderly patients. Am J Surg (1991) 1.20

Pancreatogastrostomy: a safe drainage procedure after pancreatoduodenectomy. Surgery (1990) 1.18

Management of small unilateral renal cell carcinomas: radical versus nephron-sparing surgery. Urology (1995) 1.13

The pyridoxal- and pyridoxal 5'-phosphate-catalysed non-enzymic degradations of l-serine o-sulphate and related compounds. Biochem J (1968) 1.13

Elliptic flow of charged particles in Pb-Pb collisions at sqrt[S(NN)] = 2.76 TeV. Phys Rev Lett (2010) 1.12

Particle-yield modification in jetlike azimuthal dihadron correlations in Pb-Pb collisions at √s(NN)=2.76 TeV. Phys Rev Lett (2012) 1.11

The PAX gene egl-38 mediates developmental patterning in Caenorhabditis elegans. Development (1997) 1.10

Identification and characterization of genes that interact with lin-12 in Caenorhabditis elegans. Genetics (1997) 1.09

The bromodomain protein LIN-49 and trithorax-related protein LIN-59 affect development and gene expression in Caenorhabditis elegans. Development (2000) 1.09

Block of an ether-a-go-go-like K(+) channel by imipramine rescues egl-2 excitation defects in Caenorhabditis elegans. J Neurosci (1999) 1.07

Analysis of dominant mutations affecting muscle excitation in Caenorhabditis elegans. Genetics (1995) 1.07

Higher harmonic anisotropic flow measurements of charged particles in Pb-Pb collisions at sqrt(s(NN)) = 2.76  TeV. Phys Rev Lett (2011) 1.05

Extrahepatic biliary obstruction secondary to metastatic cancer. Am J Surg (1981) 1.03

Tricuspid stenosis secondary to metastatic melanoma. Cancer (1977) 1.02

Mutants of a temperature-sensitive two-P domain potassium channel. J Neurosci (2000) 1.01

Transhiatal versus transthoracic esophagectomy for adenocarcinoma of the distal esophagus and cardia. Am J Surg (1996) 1.00

Genetics in rhythm. Trends Genet (1997) 0.99

Characterization of seven genes affecting Caenorhabditis elegans hindgut development. Genetics (1999) 0.99

Enzymes of type II fatty acid synthesis and apicoplast differentiation and division in Eimeria tenella. Int J Parasitol (2006) 0.98

The critical hypogastric circulation. Am J Surg (1987) 0.97

Hickman-Broviac catheters. Indications and results. Am J Surg (1980) 0.97

Significance of tumor spread in adenocarcinoma of the ampulla of Vater. Am J Surg (1989) 0.97

Strange baryon resonance production in sqrt s NN=200 GeV p+p and Au+Au collisions. Phys Rev Lett (2006) 0.96

Synergistic effects of feeding and dexamethasone on serum leptin levels. J Clin Endocrinol Metab (1998) 0.95

Behavioral defects in C. elegans egl-36 mutants result from potassium channels shifted in voltage-dependence of activation. Neuron (1997) 0.95

Scanning tunnelling microscopy observations of biomolecules on layered materials. Faraday Discuss (1992) 0.95

Suppressors of transforming growth factor-beta pathway mutants in the Caenorhabditis elegans dauer formation pathway. Genetics (2000) 0.94

Centrality dependence of the charged-particle multiplicity density at midrapidity in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2011) 0.93

Transverse-momentum and collision-energy dependence of high-pT hadron suppression in Au+Au collisions at ultrarelativistic energies. Phys Rev Lett (2003) 0.93

Evidence from d+Au measurements for final-state suppression of high-p(T) hadrons in Au+Au collisions at RHIC. Phys Rev Lett (2003) 0.92

Electrophoresis of ( 35 S) sulphated insulin. Immunological and biological properties of the isolated electrophoretic components. Horm Metab Res (1971) 0.92

Advanced gastric leiomyosarcoma. Am Surg (1989) 0.91

Two-cell to N-cell heterogeneous, inhibitory networks: precise linking of multistable and coherent properties. J Comput Neurosci (2005) 0.90

Cell interactions involved in development of the bilaterally symmetrical intestinal valve cells during embryogenesis in Caenorhabditis elegans. Development (1992) 0.89

Thrombolytic therapy for catheter-related thrombosis. Am J Surg (1993) 0.89

Air-stable full-visible-spectrum emission from silicon nanocrystals synthesized by an all-gas-phase plasma approach. Nanotechnology (2008) 0.88

The use and abuse of digitalis in the elderly. Gerontol Clin (Basel) (1971) 0.88

Aortoiliac reconstruction combined with nonvascular operations. Am J Surg (1983) 0.87

Using heterogeneity to predict inhibitory network model characteristics. J Neurophysiol (2004) 0.87

Role of herniography in the diagnosis of occult hernias. Am J Surg (1991) 0.87

The role of pancreatojejunostomy in patients without dilated pancreatic ducts. Am J Surg (1994) 0.85

Nonthermal plasma synthesized freestanding silicon-germanium alloy nanocrystals. Nanotechnology (2009) 0.85

Cost and effectiveness of a Geriatric Day Hospital. J R Coll Physicians Lond (1982) 0.84

Radioiodine therapy for differentiated thyroid carcinoma. Am J Surg (1988) 0.84

Aortoesophageal fistula: report of a successfully managed case and review of the literature. J Vasc Surg (1992) 0.84

A novel cosmetic approach to treat thinning hair. Br J Dermatol (2011) 0.84

Prognosis of nerve injuries incurred during acute trauma to peripheral arteries. Am J Surg (1980) 0.84

Suppression of hadrons with large transverse momentum in central Au+Au collisions at root square[s(NN)] = 130 GeV. Phys Rev Lett (2001) 0.84

Critical analysis of treatment of stage II and stage III melanoma patients with immunotherapy. Ann Surg (1976) 0.83

Hemodynamics of the hypogastric arterial circulation. J Vasc Surg (1989) 0.83

Azimuthal charged-particle correlations and possible local strong parity violation. Phys Rev Lett (2009) 0.83

Elliptic flow in Au+Au collisions at square root(S)NN = 130 GeV. Phys Rev Lett (2001) 0.82

Subtotal parathyroidectomy for secondary hyperparathyroidism. Surgery (1984) 0.81

Therapeutic alternatives in patients with esophageal cancer. Am J Surg (1985) 0.81

DNA vaccination against the parasite enzyme gamma-glutamylcysteine synthetase confers protection against Leishmania donovani infection. Vaccine (2007) 0.81

Reversal of a muscle response to GABA during C. elegans male development. J Neurosci (1995) 0.81

Hemodynamics of the inferior mesenteric arterial circulation. J Vasc Surg (1990) 0.80

Charge separation relative to the reaction plane in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2013) 0.80